Alkermes plc. — Director's Dealing 2020

Jun 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2020-06-07

Reporting Person: Hopkinson Craig C. (EVP R&D, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-07	Ordinary Shares	M	1250	—	Acquired	15201	Direct
2020-06-07	Ordinary Shares	F	368	$17.19	Disposed	14833	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-07	Restricted Stock Unit Award	$0	M	1250	Disposed		Ordinary Shares (1250)	Direct

Footnotes

F1: Shares subject to the restricted stock unit award vest in four equal annual installments commencing on 6/7/18.